Evaluation of Ciprofloxacin for Inhalation to Cystic Fibrosis Patients With P. Aeruginosa
NCT01090908
·
clinicaltrials.gov ↗
WITHDRAWN
Status
INDUSTRY
Sponsor class
Conditions
Cystic Fibrosis
Interventions
DRUG:
Antibiotic
Sponsor
Aradigm Corporation